GDUFA II: Industry Shares Stage With FDA
Executive Summary
Public meeting departs from usual format, allowing industry representatives to sit next to FDA and answer audience questions as generic during user fee agreement outlined.
You may also be interested in...
Generic User Fee Renewal Talks Faced 'Buyer's Remorse' From GDUFA I
Industry dismay at slow pace of ANDA approvals and FDA communications in early years of first user fee agreement factored into GDUFA II negotiations.
Generic User Fee Renewal Talks Faced 'Buyer's Remorse' From GDUFA I
Industry dismay at slow pace of ANDA approvals and FDA communications in early years of first user fee agreement factored into GDUFA II negotiations.
ANDA Holder Fee Will Start With Industry-Driven Database 'Clean-Up'
FDA is again relying on sponsor self-reporting as it launches GDUFA II.